AWM
ABMD

Affinity Wealth Management’s Abiomed Inc ABMD Stock Holding History

Affinity Wealth Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,269
Closed -$362K – 108
2019
Q1 		$362K Sell
1,269
-120
-9% -$39.9K 0.14% 73
2018
Q4 		$451K Buy
+1,389
New +$482K 0.27% 57
2017
Q1 		– Sell
-3,176
Closed -$358K – 79
2016
Q4 		$358K Hold
3,176
– – 0.2% 37
2016
Q3 		$408K Sell
3,176
-142
-4% -$17K 0.27% 28
2016
Q2 		$363K Buy
3,318
+1,205
+57% +$120K 0.25% 29
2016
Q1 		$200K Buy
+2,113
New +$178K 0.12% 50

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
AAMU
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

Affinity Wealth Management's ABMD Position: Q2 2019 in Review

Affinity Wealth Management sold out of Abiomed Inc (ABMD) in Q2 2019, closing a stake of 1,269 shares — an estimated $362K sold.

Affinity Wealth Management first reported a position in ABMD in Q1 2016 and held it in 6 quarters. The position peaked at $451K in Q4 2018. 483 funds tracked by Wall St. Rank hold ABMD as of Q2 2019.

  • Affinity Wealth Management reported no remaining Abiomed Inc position as of Q2 2019 after selling out during the quarter.
  • Affinity Wealth Management sold 1,269 Abiomed Inc shares in Q2 2019, an estimated $362K.
  • Affinity Wealth Management first reported a position in Abiomed Inc in Q1 2016 and held it in 6 quarters.
  • Affinity Wealth Management's Abiomed Inc position peaked at $451K in Q4 2018.
  • 483 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2019.

Based on Affinity Wealth Management's 13F filing for Q2 2019, filed 24 Jul 2019.